Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annalisa Bramati

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Nephrology|July 7, 2024
Osimertinib in a patient with end-stage kidney disease not on hemodialysisMarta Pirovano, Andrea Luciani, Giulia Vanessa Re Sartò, et al.
Anti-Cancer Drugs|June 28, 2012
Safe chemotherapy and hormone therapy for treating early breast cancer in a glucose 6-phosphate dehydrogenase-deficient patient: case reportNicla La Verde, Annalisa Bramati, Serena Girelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Multiple myeloma with prostate involvement: a case reportNicla La Verde, Anna Moretti, Annalisa Bramati, et al.
Journal of Bone and Mineral Metabolism|February 21, 2014
Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastasesAnnalisa Bramati, Serena Girelli, Gabriella Farina, et al.
Future Oncology (London, England)|October 26, 2013
Tumor shrinkage and improved quality of life in a heavily pretreated metastatic breast cancer patient treated with eribulinNicla La Verde, Sheila Piva, Monica Ganzinelli, et al.
Cancer Treatment Reviews|February 18, 2014
Efficacy of biological agents in metastatic triple-negative breast cancerAnnalisa Bramati, Serena Girelli, Valter Torri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 15, 2010
Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysisElena Galfrascoli, Sheila Piva, Michela Cinquini, et al.
Plos One|December 7, 2017
The prognostic role of tumor size in early breast cancer in the era of molecular biologyAnaid Anna Kasangian, Giorgio Gherardi, Elena Biagioli, et al.
Plos One|April 12, 2013
Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patientsMarina Chiara Garassino, Sheila Piva, Nicla La Verde, et al.
Tumori|October 10, 2014
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysisElena Collovà, Antonella Ferzi, Giuseppa Scandurra, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Nephrology|July 7, 2024
Osimertinib in a patient with end-stage kidney disease not on hemodialysisMarta Pirovano, Andrea Luciani, Giulia Vanessa Re Sartò, et al.
Anti-Cancer Drugs|June 28, 2012
Safe chemotherapy and hormone therapy for treating early breast cancer in a glucose 6-phosphate dehydrogenase-deficient patient: case reportNicla La Verde, Annalisa Bramati, Serena Girelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Multiple myeloma with prostate involvement: a case reportNicla La Verde, Anna Moretti, Annalisa Bramati, et al.
Journal of Bone and Mineral Metabolism|February 21, 2014
Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastasesAnnalisa Bramati, Serena Girelli, Gabriella Farina, et al.
Future Oncology (London, England)|October 26, 2013
Tumor shrinkage and improved quality of life in a heavily pretreated metastatic breast cancer patient treated with eribulinNicla La Verde, Sheila Piva, Monica Ganzinelli, et al.
Cancer Treatment Reviews|February 18, 2014
Efficacy of biological agents in metastatic triple-negative breast cancerAnnalisa Bramati, Serena Girelli, Valter Torri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 15, 2010
Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysisElena Galfrascoli, Sheila Piva, Michela Cinquini, et al.
Plos One|December 7, 2017
The prognostic role of tumor size in early breast cancer in the era of molecular biologyAnaid Anna Kasangian, Giorgio Gherardi, Elena Biagioli, et al.
Plos One|April 12, 2013
Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patientsMarina Chiara Garassino, Sheila Piva, Nicla La Verde, et al.
Tumori|October 10, 2014
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysisElena Collovà, Antonella Ferzi, Giuseppa Scandurra, et al.
Pageof 2